Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Computerized healthcare has undergone rapid development thanks to the advances in medical imaging and machine learning technologies. Especially, recent progress on deep learning opens a new era for multimedia based clinical decision support. In this paper, we use deep learning with brain network and clinical relevant text information to make early diagnosis of Alzheimer's Disease (AD). The clinica...
BACKGROUND: We present our results in the International challenge for automated prediction of MCI from MRI data. We evaluate the performance of MRI-based neuromorphometrics features (nMF) in the classification of Healthy Controls (HC), Mild Cognitive Impairment (MCI), converters MCI (cMCI) and Alzheimer's Disease (AD) patients.
BACKGROUND: Alzheimer's disease (AD) is the most common cause of neurodegenerative dementia in the elderly population. Scientific research is very act...
OBJECTIVE: To discover lead lupane triterpenoid's potential isolated from Pueraria lobata roots against β-site amyloid precursor protein cleaving enzy...
Alzheimer's disease (AD) has been not only a substantial financial burden to the health care system but also an emotional burden to patients and their...
Alzheimer's disease (AD) is a highly prevalent condition and its prevalence is expected to further increase due to the aging of the general population...
OBJECTIVE: To conduct the first support vector machine (SVM)-based study comparing the diagnostic accuracy of T1-weighted magnetic resonance imaging (...
OBJECTIVES: This scoping study is the first step of a multiphase, international project aimed at designing a homecare robot that can provide functiona...
The use of Intelligent Assistive Technology (IAT) in dementia care opens the prospects of reducing the global burden of dementia and enabling novel op...
OBJECTIVE: Diabetic neuropathy is a chronic and often disabling condition that affects a significant number of individuals with diabetes mellitus (DM)...
BACKGROUND AND OBJECTIVES: A huge number of solutions based on computational systems have been recently developed for the classification of cognitive ...
BACKGROUND: Socially assistive robots are increasingly used as a therapeutic tool for people with dementia, as a means to improve quality of life thro...
BACKGROUND AND OBJECTIVE: Alzheimers disease (AD) is a fatal neurodegenerative disease and the onset of AD is insidious. Full understanding of the AD-...
OBJECTIVES: To test the effects of individual, nonfacilitated sessions with PARO (version 9), when compared against a look-alike plush toy and usual c...
Utilizing [18F]-AV-1451 tau positron emission tomography (PET) as an Alzheimer disease (AD) biomarker will require identification of brain regions tha...
BACKGROUND: Predicting progression from a stage of Mild Cognitive Impairment to dementia is a major pursuit in current research. It is broadly accepte...
BACKGROUND AND OBJECTIVE: The differentiation of mild cognitive impairment (MCI), which is the prodromal stage of Alzheimer's disease (AD), from norma...
Hereditary (familial) amyloid polyneuropathy (FAP) is a systemic disease that includes a sensorimotor polyneuropathy related to transthyretin (TTR) mu...
Monitoring effects of disease or therapeutic intervention on brain function is increasingly important for clinical trials, albeit hampered by inter-in...
OBJECTIVE: In many decision support systems, some input features can be marginal or irrelevant to the diagnosis, while others can be redundant among e...